Successfully Transforming a Pricing Organization
|
|
- Bridget Randall
- 5 years ago
- Views:
Transcription
1 Successfully Transforming a Pricing Organization Simon-Kucher project insights and experiences COLOURBOX/stanzkul October,
2 "The secret of all victory lies in the organization of the non-obvious." Marcus Aurelius & Partners Simon-Kucher on Transforming a Pricing Organization.pptx 2
3 The pricing organization plays an essential role in capturing value throughout a product s lifecycle PRODUCT LIFECYCLE Net product revenue 1 Reduces R&D costs by prioritizing higher payoff opportunities Product launch 3 Increases incremental peak revenue Shorten this phase Raise the peak of this phase Time 2 Accelerates revenue by getting "wanted" products/services faster to market Simon-Kucher on Transforming a Pricing Organization.pptx 3
4 A strong pricing organization looks to the future Photocase/Traumfaengerin Simon-Kucher on Transforming a Pricing Organization.pptx 4
5 because markets are constantly changing; let s look back at the last 15 years Internet Digitalization New business models Photos by COLOURBOX Cheap access to information Price transparency Complexity of channel management Competition shifting who builds good products for customers vs. who builds good knowledge on customer s preferences Shareconomy Pay per use Freemium etc. Simon-Kucher on Transforming a Pricing Organization.pptx 5
6 Example: Pharmaceuticals Top selling products in 2000 Top selling products in 2015 Claritin Glucophage Neurotin Lipitor PravacholZocor Prozac Premarin Oxycontin Celebrex Augmentin Paxil Norvasc Zyprexa Cipro Prevacid Zoloft Prilosec Vioxx Revlimid Enbrel Harvoni Neulasta Xarelto Givec Lantus Advair Herceptin Sovaldi Remicade Copaxone Januvia LyricaHumira Rituxan Crestor Abilify Avastin Large patient populations Lower unmet need Small molecules Lower price Smaller patient populations Higher unmet need Biologics Higher price ; National Institute for Health Care Management; PharmaCompass Simon-Kucher on Transforming a Pricing Organization.pptx 6
7 Case study: pharmaceutical company with a pricing organization preparing to scale product portfolio Photos by COLOURBOX Sub-optimal organizational alignment in determining the price potential for products in development and those on the market Inconsistencies in the approach to gathering internal and external pricing insights to inform product development and manage prices after launch Different expectations (including terminology) in the organization about the precision and granularity of deliverables from a functional area (e.g., global pricing) Simon-Kucher on Transforming a Pricing Organization.pptx 7
8 To successfully transform the pricing organization, the company needed to evaluate: What When How Photos by COLOURBOX Who Simon-Kucher on Transforming a Pricing Organization.pptx 8
9 What should we be doing and When? Creating a framework When? Product development Post-launch What? Category #1 Activity #1 #2 Stage #1 Stage #2 Growth Maturity Activity #2 Activity #3 #3 Activity #4 Activity #5 Activity #6 Activity # Activity # Activity #7 Activity # Activity # Activity #8 Activity #9 Activity # Activity # can help provide: Common lexicon Accountability Expectation setting Better communication Simon-Kucher on Transforming a Pricing Organization.pptx 9
10 Life Sciences example: Framework Before Phase I Phase IIa Phase IIb Too early Too late Prep for Phase III Target price range? Did not happen Too robust After Payer engagement Evidence plan Value materials Pricing Ph. I Ph. IIa Benchmarks Payer environme nt Payerinformed Ph. IIb trial design Early price range Ph. IIb Stakeholder mapping Prep for Ph. III Payer-informed Ph. III trial design Emerging value messages Refined price range Not too early, not too late, well planned and organized Simon-Kucher on Transforming a Pricing Organization.pptx 10
11 How should we be doing what we need to do? Creating a how-to guide and templates Template for Activity How-to guide for Activity Target price range What do we need? Where do we get what we need? What do we do once we get it? What is the final output Segment #1 Segment #2 Segment we #3are preparing? What do we do with the output? can help ensure: Consistency Smooth on-boarding Simon-Kucher on Transforming a Pricing Organization.pptx 11
12 Life Sciences example: How-to guide Before Outsource or internal? Necessary materials? Needs for customer research? Which stakeholders to approach? Budget? 100k or 1M? After Payer-informed Payer-informed Phase IIb trial design Payer-informed Phase Phase IIb IIb trial trial design design Draft Ph. IIb trial design from Draft Ph. IIb trial design from Inputs Clinical Draft Ph. IIb trial design from Inputs Clinical Inputs Target Clinical product profile Target product profile Hypothesize Target product potential profile trial Hypothesize potential trial comparators, Hypothesize endpoints, potential and trial comparators, endpoints, and outcomes comparators, endpoints, and outcomes Engage outcomes an external vendor to Engage an external vendor to Process conduct Engage qualitative an external research consultant Process conduct qualitative research Process with to payers interview customers (payers) with payers Research Research should should understand Research should understand the the price price trade-off trade-off different of different the price trade-off of different trial trial scenarios scenarios trial scenarios Price potential under different Output Price potential under different Output trial Price designs/outcomes potential under different Output trial designs/outcomes trial designs/outcomes Budget for Budget for $300k - $450k outsourcing Budget for $300k - $450k outsourcing outsourcing $xxx Simon-Kucher on Transforming a Pricing Organization.pptx 12
13 Life Sciences example: Templates Before After Highly variable Confusing Lacks key info Simon-Kucher on Transforming a Pricing Organization.pptx 13
14 Who will we need to execute what we need to do? Creating a RACI and role profiles Title # needed Responsibilities Relevant expertise Key account manager 2 Engages customers regarding Coordinates with Negotiations regarding RACI Function #1 Function #2 Function #3 Activity #1 R A C I Activity #2 R I A C Activity #3 R I A I can lead to: Regular communication across the organization Finding those with the right expertise ; R = Responsible, A = Accountable, C = Consulted, I = Informed Simon-Kucher on Transforming a Pricing Organization.pptx 14
15 Life Sciences example: RACI Before After Activity Global Affiliate Medical Pricing Affairs HEOR Public Affairs C-suite Brand team Unclear roles and responsibilities Irregular communication Functional silos Payerinformed Ph. IIb trial design Payerinformed Ph. III trial design Launch pricing strategy R A C C C R C A C C C R I C C I A C Value story R I A C I A A Stakeholder mapping R C I A A ; R = Responsible, A = Accountable, C = Consulted, I = Informed Simon-Kucher on Transforming a Pricing Organization.pptx 15
16 Life Sciences example: Role profile Before After Title: Tender Manager Positions available 1 Market moving from single product negotiations, where in-house knowledge exists, to tenders, where in-house knowledge lacks Responsibilities Relevant expertise Pro-actively engages with payers in the development of tender requests Coordinates with relevant internal stakeholders to develop proposals in response to tender requests Defends proposals to customers. Prior experience in therapeutic area Prior experience developing tender proposals Knowledgeable about markets Simon-Kucher on Transforming a Pricing Organization.pptx 16
17 Once the new pricing organization was set-up, training staff and updating skills was a must COLOURBOX/ Pressmaster Simon-Kucher on Transforming a Pricing Organization.pptx 17
18 In summary The pricing organization plays an essential role in capturing value Value propositions for customers are not static as markets change over time and are even disrupted from time to time A pricing organization needs to anticipate the changing requirements for capturing value and adapt as needed Successful change requires a regular evaluation of 4 dimensions What activities should the pricing organization undertake? When should these activities be done? How should these activities be done? Who is involved in these activities and what role do they play? Updating the pricing organization s processes and toolkit is an ongoing process and requires ongoing training Building a world-class pricing organization should be a top priority COLOURBOX/Dmitry-Naumov Simon-Kucher on Transforming a Pricing Organization.pptx 18
Identifying Critical Factors Pre-launch
Identifying Critical Factors Pre-launch Incorporate pricing and market access into product planning Eric M. Bachman, Director Boston office One Canal Park Cambridge, MA 02141, USA Tel. +1 617 231 4592
More informationImprove your probability. of success
Improve your probability of success FROM PIPELINE TO PORTFOLIO TO POPULATION HEALTH TM Creating a healthier world will require the industry s best thinking and resources. It will also demand working together
More informationUNLEASHING MEDICAL AFFAIRS
UNLEASHING MEDICAL AFFAIRS DEC 2017 UNLEASHING MEDICAL AFFAIRS Sweeping changes across the pharmaceutical industry have heightened the expectations for Medical Affairs and have created an unprecedented
More informationDEMONSTRATING YOUR MEDICINE S VALUE TO ALL STAKEHOLDERS TRUSTED COMMERCIALIZATION AND MARKET ACCESS EXPERTISE
CATALYSTS DRIVING SUCCESSFUL DECISIONS IN LIFE SCIENCES DEMONSTRATING YOUR MEDICINE S VALUE TO ALL STAKEHOLDERS TRUSTED COMMERCIALIZATION AND MARKET ACCESS EXPERTISE WHEN COMMERCIALIZING A MEDICINE, IT
More informationRapid Path to Recruiting
Gina Morton Associate Director, Scientific Sourcing Head of US Site Contracts Genentech, a Member of the Roche Group Disclaimer: Speaker is participating in an individual capacity and not representing
More informationJordi Aparici Market Intelligence Consultant
Jordi Aparici Market Intelligence Consultant Helping pharma companies make robust decisions based on market, competitors and patient knowledge Market Intelligence Strategy Marketing Market Research Data
More informationAn integrated model approach to improve the management of marketed products
Insight brief Regulatory and safety integration An integrated model approach to improve the management of marketed products Leo Dodds, Principal, Quintiles Advisory Services John Rogers, Engagement Leader,
More informationBenchmarking the Pharma Industry s HEOR Functions
EW PR EV I Benchmarking the Pharma Industry s HEOR Functions Info@ISRreports.com 2013 Industry Standard Research www.isrreports.com Report Overview This report provides pharmaceutical and biotech organizations
More informationDaitan White Paper The Software Development versus Maintenance Dilemma COMMON MISCALCULATIONS IMPACT REVENUE AND MARKET SHARE
Daitan White Paper The Software Development versus Maintenance Dilemma COMMON MISCALCULATIONS IMPACT REVENUE AND MARKET SHARE Highly Reliable Software Development Services http://www.daitangroup.com Daitan
More informationMARKET RESEARCH AT ADELPHI SEPTEMBER 2016
MARKET RESEARCH AT ADELPHI SEPTEMBER 2016 Adelphi Research conducts primary market research, exclusively in the healthcare industry Parent Company: Omnicom Group Providing full-service primary custom marketing
More informationLEVERAGING OUR BIOLOGICS EXPERTISE IN BIOSIMILARS SCOTT FORAKER VICE PRESIDENT AND GENERAL MANAGER, BIOSIMILARS
LEVERAGING OUR BIOLOGICS EXPERTISE IN BIOSIMILARS SCOTT FORAKER VICE PRESIDENT AND GENERAL MANAGER, BIOSIMILARS SAFE HARBOR STATEMENT This presentation contains forward-looking statements that are based
More informationBuild a deeper appreciation and understanding of HTA needs into your wider organization. Stefan Holmstrom
Build a deeper appreciation and understanding of HTA needs into your wider organization Stefan Holmstrom Executive Director HEOR Medical Affairs, Global Astellas Pharma 1 Outline of presentation 1. Changing
More informationPortfolio Marketing. Research and Advisory Service
Portfolio Marketing Research and Advisory Service SiriusDecisions Team Jeff Lash VP and Group Director, Go-to-Market Christina McKeon Service Director, Portfolio Marketing Tyler Anderson Team Leader, Account
More informationWinning Pitch Decks. February 5, 2015
Winning Pitch Decks February 5, 2015 BYOBB Facts Different deliverables this year Pitch Deck - Annotated Executive Summary Financials should include cost to launch or get to a critical milestone, and be
More informationProduct Introduction Primer for 2019
Product Introduction Primer for 2019 Product Introduction Primer for 2019 Published: 2 January 2019 ID: G00375818 Analyst(s): Eric Trenk, Carrie Cowan, Ron Burns Product introduction is the cross-functional
More informationTransforming Business Needs into Business Value. Path to Agility May 2013
Transforming Business Needs into Business Value Path to Agility May 2013 Agile Transformation Professional services career Large scale projects Application development & Integration Project management
More informationPreparing your organization for a Human Resource Outsourcing implementation
IBM Global Technology Services Thought Leadership White Paper April 2013 Preparing your organization for a Human Resource Outsourcing implementation How to collaborate for a more successful transition
More informationR&D Portfolio Planning In- and Out-licensing of Medicines
R&D Portfolio Planning In- and Out-licensing of Medicines Portfolio Planning Role of portfolio management Importance to Industry Tools, methods and models to make Go/No-Go decisions To help Prioritise
More informationPAPER CX Governance. CX Governance. Align your organization around a unified CX objective to achieve better business results. MARITZCX.
CX Governance Align your organization around a unified CX objective to achieve better business results. 1 BUILDING A SUCCESSFUL CX PROGRAM IN A DIGITAL WORLD Your success ultimately depends on how well
More informationGoldman Sachs Key Debates In Biosimilars Conference
Goldman Sachs Key Debates In Biosimilars Conference Diem Nguyen Regional President North America, Global Established Pharmaceuticals April 2, 2015 1 2 Forward Looking Statements Our discussions during
More informationWebinar Series Physician Relations. Referral Development. Advancing the Physician Relations Program Structure
Webinar Series 2017 Physician Relations Referral Development Advancing the Physician Relations Program Structure Webinar Series 2017 Physician Relations Today s Agenda You will Learn: What are the right
More informationRISING COSTS FOR PATENTED DRUGS DRIVE GROWTH OF PHARMACEUTICAL SPENDING IN THE U.S.
RISING COSTS FOR PATENTED DRUGS DRIVE GROWTH OF PHARMACEUTICAL IN THE U.S. Rising Costs for Patented Drugs Drive Growth of Pharmaceutical Spending in the U.S. ( 1 ) BLUE CROSS BLUE SHIELD, THE HEALTH OF
More informationWhat makes a good Category Manager key imperatives and soft skills
1 Category Management defined What makes a good Category Manager key imperatives and soft skills 2 3 Category Management Journey a fundamental change to the way organizations approach procurement 4 Key
More informationTrends in Drug Delivery and Formulation Injectables
Trends in Drug Delivery and Formulation Injectables Tugrul T. Kararli, Ph.D., MBA President and Founder, PharmaCircle - Partnership Opportunities in Drug Delivery Conference October 5, 215 PharmaCircle
More informationAligning internal teams to secure buy-in from external stakeholders: a critical part of launch strategy
October 2015 Aligning internal teams to secure buy-in from external stakeholders: a critical part of launch strategy The commercial success of a new pharmaceutical product depends on the buy-in of disparate
More informationThe New Role of Medical Affairs in Defining and Driving Product Success
The New Role of Medical Affairs in Defining and Driving Product Success Suma Ramadas, PhD, and Susan Suponcic, PhD Syneos Health Consulting 2018 Syneos Health. All rights reserved. The Organizational Role
More informationOptimize Your Medical Affairs Team s Influence in a Start-up Organization
Optimize Your Medical Affairs Team s Influence in a Start-up Organization Rachel Couchenour, PharmD, MBA Sr. Director, Medical Affairs Mateon Therapeutics Objectives Discover the unique challenges faced
More informationOverview and Frequently Asked Questions
Overview and Frequently Asked Questions Overview Oracle Buys Relsys: Adds advanced drug safety and risk management applications to extend Oracle s leadership in health sciences Oracle has acquired Relsys
More informationFrom discussion to implementation: How to negotiate and implement a risk-sharing agreement
July 2017 From discussion to implementation: How to negotiate and implement a risk-sharing agreement At the table with payers and manufacturers Background The groundswell of interest in value-based drug
More informationMichael Malone, MD Kellie Flood, MD Kevin Foley, MD October 15, 2015
Basics of Writing a Business Plan Michael Malone, MD Kellie Flood, MD Kevin Foley, MD October 15, 2015 Background Requests for business plans from physicians are increasing as reimbursement shrinks and
More informationPlanning of Application
2016 Good Registration Management Regulatory Science Center of Excellence Pilot Workshop Planning of Application Moderator: Speaker: Jin Shun, AbbVie Thean Soo Lo, J&J Sannie Chong, Roche Agenda 10:00~10:05
More informationStrategic Plan. Uniting to care & cure
2017-2019 Strategic Plan Uniting to care & cure Table of Contents Message from the President & CEO Page 2 Overview Page 3 Mission Page 4 Core Values Page 5 2017-2019 Objectives & Strategies Page 6 Mission
More informationAre Biosimilars the Panacea for High Cost Specialty Drugs?
Are Biosimilars the Panacea for High Cost Specialty Drugs? Mid-sized Retirement and Healthcare Plan Management San Francisco, CA March 27, 2018 2018. Innovative Rx Strategies, LLC. All rights reserved.
More informationBank of America Merrill Lynch Healthcare Conference. September 13, 2013
Bank of America Merrill Lynch Healthcare Conference September 13, 2013 Safe Harbor Statement This presentation contains forward-looking statements that are based on management s current expectations and
More informationSzabolcs Barotfi Ph.D.
Szabolcs Barotfi Ph.D. Manufacturer: Bayer Withdrawn in 2001 (4 years after registration) Financial loss: 1.2 bn $ Manufacturer: MSD Withdrawn in 2004 (5 years after registration) Financial loss: 2 bn
More informationWinning at Implementation, Losing at Effectiveness
Winning at Implementation, Losing at Effectiveness 5 Ways to Achieve Better Win/Loss Results Based on the 2017 Fletcher/CSI Global Win/Loss Survey Results (Updated from the 2015 Fletcher/CSI Global Win/Loss
More information2018 North American Real-World Evidence Enterprise Solutions Market Leadership Award
2018 North American Real-World Evidence Enterprise Solutions Market Leadership Award 2018 2018 NORTH AMERICAN REAL-WORLD EVIDENCE ENTERPRISE SOLUTIONS MARKET LEADERSHIP AWARD Contents Background and Company
More informationCommercial Pricing and Contracting 101
Commercial Pricing and Contracting 101 Reimbursement and Contracting CBI Conference Philadelphia, PA February 4, 2016 Althea Danzey, Director of Contracting Tina Still, Senior Manager of Contracting Eisai
More informationManaging Disruption requires Fostering Innovation and Scaling the Digital Supply Chain
Managing Disruption requires Fostering Innovation and Scaling the Digital Supply Chain The growth of digital business, acceleration of digitalization and demand for sustainability present significant challenges
More informationGenpact Intelligent Operations SM
PROVIDE VISIBILITY Genpact Intelligent Operations SM Making enterprises more competitive, with operations that sense, act and learn from the outcome of actions, at scale Foreword Intelligent Operations
More informationStepping Into the Future of Pharmacovigilance
PAREXEL White Paper Stepping Into the Future of Pharmacovigilance The What, Why and How of Knowledge Process Outsourcing Mature biopharmaceutical products with established safety profiles frequently represent
More informationThe Anatomy of a B-to-B Marketing Plan
May 26, 2016 The Anatomy of a B-to-B Marketing Plan Craig Moore Service Director Marcia Trask Research Director 2 2016 SiriusDecisions. All Rights Reserved 3 2016 SiriusDecisions. All Rights Reserved Executive
More informationconfidence. High-quality pharmaceutical market research that enables confident tactical and strategic business decisions
act with confidence. High-quality pharmaceutical market research that enables confident tactical and strategic business decisions ISR is a full-service pharmaceutical market research firm that delivers
More informationValue Messages: Developing, Incorporating, and Making Use of a Core Strategic Tool
Value Messages: Developing, Incorporating, and Making Use of a Core Strategic Tool Kati Copley-Merriman, MBA, MS Vice President, Regulatory and Health Outcomes Strategy RTI Health Solutions Stephanie Barrows,
More informationCapital Markets Day. 14 December 2010
Capital Markets Day 14 December 2010 0 Capital Markets Day 14 December 2010 Agenda Introduction Grayling Huntsworth Health Q&A and discussion 1 Capital Markets Day 14 December 2010 Introduction Four strong
More informationStrategic Plan. Uniting to care & cure
2017-2020 Strategic Plan Uniting to care & cure Table of Contents Message from the President & CEO Page 2 Overview Page 3 Mission Page 4 Core Values Page 5 2017-2020 Objectives & Strategies Page 6 Mission
More informationTENDER MANAGEMENT PRACTICES IN THE LIFE SCIENCES INDUSTRY SURVEY RESULTS, REPORT 1: THE TENDER ORGANIZATION BACKGROUND BENCHMARKING STUDY
BENCHMARKING SURVEY RESULTS TENDER MANAGEMENT PRACTICES IN THE LIFE SCIENCES INDUSTRY SURVEY RESULTS, REPORT 1: THE TENDER ORGANIZATION AN ASSESSMENT OF HOW LIFE SCIENCES MANUFACTURERS ORGANIZE AND GOVERN
More informationBreaking the Silo Mentality Working With Opinion Leaders
CBI s 2 nd Annual KOL Conference Breaking the Silo Mentality Working With Opinion Leaders Kashif Chaudhry Objectives Share a view on the changing environment impacting the pharmaceutical industry and KOL
More informationIDEA TO IMPACT: Guide to Introduction and Scale of Global Health Innovations. Toolkit Overview
IDEA TO IMPACT: Guide to Introduction and Scale of Global Health Innovations Toolkit Overview v1.0, 2015 Context/Disclaimer These templates, examples, and tools have been compiled to provide some inspiration
More informationHOW TO IDENTIFY & PRIORITIZE TRIAL STAKEHOLDERS
HOW TO IDENTIFY & PRIORITIZE TRIAL STAKEHOLDERS The following editable chart can help you, the trial designer, identify and prioritize the stakeholders you may need to engage to ensure the success of your
More informationMarketing Research to Support the Stage Gate New Product Development Process
Marketing Research to Support the Stage Gate New Product Development Process Agile. Iterative. Informed. Fast. These are hallmarks of today s effective new product development, with the goal of establishing
More informationWHITE PAPER COLLABORATING WITH DIGITAL AGENCIES USING A SHARED TECHNOLOGY PLATFORM
COLLABORATING WITH DIGITAL AGENCIES USING A SHARED TECHNOLOGY PLATFORM Are you struggling to coordinate with digital agencies and technology service providers for the execution of your digital initiatives?
More informationBearingPoint Process Advisory
BearingPoint Process Advisory Service Overview BearingPoint Process Advisory The BearingPoint Process Advisory combines business process management, industry expertise and innovative technology to achieve
More informationPhysician Marketing & Outreach Growing Referring Physician Lifetime Value
Growing Referring Physician Lifetime Value Gelb, An Endeavor Management Company 1011 Highway 6 South P + 281.759.3600 Suite 120 F + 281.759.3607 Houston, Texas 77077 www.gelbconsulting.com Overview Today
More informationRESEARCH REPORT. Includes complete survey data. Project Management Maturity & Value Benchmark
RESEARCH REPORT Includes complete survey data Project Management Maturity & Value Benchmark 2014 2 Project Management Maturity & Value Benchmark 2014 Introduction PM Solutions Research first surveyed organizations
More informationUnderstanding Payer Dynamics. A critical factor in maximizing brand performance. Healthcare Measurement IMS Payer Insights
Understanding Payer Dynamics A critical factor in maximizing brand performance Healthcare Measurement IMS Payer Insights Understanding Payer Dynamics A critical factor in maximizing brand performance In
More informationTeaching Others About Home Infusion Therapy: Strategies and Resources to Prove Your Value
Teaching Others About Home Infusion Therapy: Strategies and Resources to Prove Your Value Presented by: Kelly Aldridge, Regional Vice President of Sales and Marketing, Home Solutions, Northfield, NJ Top
More informationPharma EXPO 6 9 November 2016 Chicago, IL
DESIGN TO VALUE: An End-to-end Lifecycle Methodology, Enabling Customer-centric, High-quality Products, Made Efficiently and Reliably Susan Neadle Senior Director Design to Value & Product Quality Management
More informationSponsor/CRO Partnership Optimization
Insight Brief Sponsor/CRO Partnership Optimization Developing a CRO Governance Model Geoff Garabedian, Vice President and Managing Director, Consulting at Quintiles Josh Samon, Principal Life Sciences
More informationTBM Awards Nomination Questionnaire
Business Alignment Award More and more, the transformation from a technology provider to a service provider is accelerated by the cloud. Not only does the public cloud delivery model put internal IT services
More informationMergers and Acquisitions in the Biotechnology Industry
Mergers and Acquisitions in the Biotechnology Industry For venture-backed biotech companies, the approval of a new drug is a long-term prospect that requires extensive time and effort for research, development,
More informationServices Catalog. Copyright MKTDIRECTOR, LLC. All Rights Reserved
Services Catalog 1 Your Marketing, Outsourced MKTDIRECTOR helps your business grow by supporting your Marketing. MKTDIRECTOR is a vertical marketing services business that covers from the Strategic side
More informationSpeed your time to market with FDA s expedited programs
Regulatory Sciences Expediting drug approval Speed your time to market with FDA s expedited programs The faster way to marketing submission and drug approval for serious conditions and rare diseases In
More informationKey Activities. Ofer Reizes, Ph.D. Skills Development Director
Key Activities Ofer Reizes, Ph.D. Skills Development Director 1 Key Activities Core Question: What key activities required for your Value Propositions? Key Partners Key Activities Key Resources Value Proposition
More informationBiosimilar medicines: practical EU experience and perspectives. 12 Sept 2017 Adrian van den Hoven, Director General, Medicines for Europe
Biosimilar medicines: practical EU experience and perspectives 12 Sept 2017 Adrian van den Hoven, Director General, Medicines for Europe Medicines For Europe VISION Medicines for Europe Vision 2020 Our
More informationComparison of the Non-patent Drug Exclusivities Available in the United States, Canada, Europe and Japan
Comparison of the Non-patent Drug Exclusivities Available in the United States, Canada, Europe and Japan The International Economic Forum of the Americas Serge Lapointe, Ph.D. Partner, Patent Agent June
More information3. Strategic Improvement Initiatives Diagnose key improvement areas and put the right focus, resources and plans in place to drive improvement.
If you are the leader of a technology company or a Professional Services executive and you want to: Turn your Professional Services organization into a value-added profit center Learn how to maximize your
More informationBEST PRACTICES IN BEST PRACTICES IN STUDY FEASIBILITY
BEST PRACTICES IN P R E V I E W O F BEST PRACTICES IN STUDY FEASIBILITY A U G U S T, 2 0 1 6 REPORT OVERVIEW One of the primary challenges to successfully completing a clinical study is estimating the
More informationJefferies 2014 Global Healthcare Conference June 3, 2014 NYSE: Q
Jefferies 2014 Global Healthcare Conference June 3, 2014 NYSE: Q Copyright 2013 Quintiles Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking statements
More informationBIOPHARMA SOLUTIONS TM Expedite Your Drug Development Program
BIOPHARMA SOLUTIONS TM Expedite Your Drug Program Maximize the Value of Your Asset The journey of drug development can be complex stressful. But it doesn t have to be that way. Join more than 600 biopharmaceutical
More informationAdam Schechter President, U.S. Human Health
Adam Schechter President, U.S. Human Health Goldman Sachs 28th Annual Global Healthcare Conference June 13, 2007 Forward-Looking Statement This presentation contains "forward-looking statements" as that
More informationMAKING OUTCOME-BASED PAYMENTS A REALITY IN THE NHS RESEARCH STUDY: PHASE INTRODUCTION. Research Brief
MAKING OUTCOME-BASED PAYMENTS A REALITY IN THE NHS RESEARCH STUDY: PHASE 1 1.0 INTRODUCTION Cancer Research UK (CRUK) believes cancer patients should have access to the best, evidence-based innovative
More informationSurviving the Retail Revolution in Health Care
SEGMENTING TARGETING UNDERSTANDING TRUST-BUILDING REPOSITIONING ALIGNING Surviving the Retail Revolution in Health Care Competencies of Winning Hospitals and Health Systems 2014 The Advisory Board Company
More informationData Warehousing provides easy access
Data Warehouse Process Data Warehousing provides easy access to the right data at the right time to the right users so that the right business decisions can be made. The Data Warehouse Process is a prescription
More informationEmployee Engagement Certificate Program Certified Employee Engagement Specialist
Certificate Program Outline This is an outline for the 40 hour Employee Engagement Specialist Certificate Program. The program is made up of ten 4-hour sessions delivered monthly. Each session will include
More informationJOB DESCRIPTION contract
JOB DESCRIPTION contract Job Title Reports to Acquisition Marketing Manager Chief Marketing Officer This important growth role is responsible for implementing a number of high impact projects& campaigns
More informationCrafting Your Value Proposition Practice Transformation Academy Webinar #5
Crafting Your Value Proposition Practice Transformation Academy Webinar #5 Steven E. Ramsland, EdD CEO, Catalyst Health Resources LLC November 15, 2017 Drucker s 5 Most Important Questions The 5 Most Important
More informationHow Structured Content Management (SCM) Is Revolutionizing the Life Sciences Industry
How Structured Content Management (SCM) Is Revolutionizing the Life Sciences Industry One can learn a lot about structured content management by playing with a pile of Lego blocks for a few days. Available
More informationMarketing Communications Essentials:
Marketing Communications Essentials: Best Practices Business to Business Marketing May 2013 I. B2B Marketing Focus Agenda II. III. Consumer vs. B2B Decision Makers Messaging: Rational or Emotional? IV.
More informationADR International ADR s Online Supply Chain Academy (OSCA) elearning Courses
Learning ADR International ADR s Online Supply Chain Academy (OSCA) elearning Courses 2016 ADR International Contents About ADR s Online Supply Chain Academy (OSCA) 3 The Strategic Sourcing Process 4 ADR
More informationGet Exactly What You Want from Your Next Contract
Payment Integrity Compass Get Exactly What You Want from Your Next Contract Your Payer Negotiations Toolkit In this toolkit, you will learn: Best practice internal communication strategies How to organize
More informationand satisfying customer needs profitably about customers, competitors and market trends through collecting primary and secondary data
The management process that is responsible for anticipating, identifying and satisfying customer needs profitably Marketing The process of gaining information about customers, competitors and market trends
More informationIntegrated Business Planning. Key insights and your way to start
Integrated Business Planning Key insights and your way to start Market leading companies use innovative cloud-based, real-time planning solutions to outrace competitors Companies today face the tremendous
More informationStatement of Work. Human Resources (HR) Health Check Engagement HR Function Process Assessment & Talent Management Process Assessment
www.pwc.com/ca Statement of Work Human Resources (HR) Health Check Engagement HR Function Process Assessment & Talent Management Process Assessment Submitted on August 8, 2017 for SPC on Finance on August
More informationMylan. Raymond James 40 th Annual Institutional Investors Conference March 05, 2019
Mylan Raymond James 40 th Annual Institutional Investors Conference March 05, 2019 Forward-Looking Statements This presentation contains forward-looking statements. These statements are made pursuant to
More informationUsing Key Performing Indicators (KPIs) to measure, improve and communicate evidence of functional performance
Quantifying impact in Market Access / HEOR Using Key Performing Indicators (KPIs) to measure, improve and communicate evidence of functional performance www.kinapse.com Executive Summary With payers around
More information_formatted. Number: Passing Score: 800 Time Limit: 120 min File Version:
810-403_formatted Number: 000-000 Passing Score: 800 Time Limit: 120 min File Version: 1.0 http://www.gratisexam.com/ 810-403 Selling Business Outcomes Version 4.0 Exam A QUESTION 1 Which two questions
More informationDavid Vidal SIMON-KUCHER & PARTNERS
David Vidal SIMON-KUCHER & PARTNERS Online dynamic pricing : Making it work for your business David Vidal Partner Paris Office www.simon-kucher.com Classical situation : Up to 45% of price change are dilutive
More informationCustomer Segmentation Does Not Work What's Wrong With It?
Customer Segmentation Does Not Work What's Wrong With It? July 2017 OSG at a Glance Offices in US, EU and Asia Over 700 projects Diverse range of leading Fortune 500 clients Reference-able C-Suite level
More informationSales & Marketing. Inspiring consumer goods sector by everis
Sales & Marketing Inspiring consumer goods sector by everis Sales & Marketing: Sales & Marketing is a sensitive area for both our clients and we, so our approaching keys are: to increase market share,
More informationDefining Strategic Metrics to Demonstrate Impact
The Value of Medical Affairs: Defining Strategic Metrics to Demonstrate Impact www.envisionpharmagroup.com The Value of Medical Affairs: Defining Strategic Metrics to Demonstrate Impact Objectives Establish
More informationTHE WISE PIVOT INTO SUPPLY CHAIN X.0
THE WISE PIVOT INTO SUPPLY CHAIN X.0 PAVING THE PATH TO PROFITABILITY IN THE DIGITAL WORLD In today s digital world, it is easier than ever to get the right products to the right places at the right time
More informationBUILDING BETTER PROJECT ORGANIZATIONS
AN INTERTHINK CONSULTING WHITE PAPER BUILDING BETTER PROJECT ORGANIZATIONS AN OVERVIEW OF INTERTHINK CONSULTING'S PROJECT MANAGEMENT OFFICE IMPLEMENTATION FRAMEWORK Contents: The Challenge of Project Management
More informationDigital customer journey, gamification and loyalty in Retail Banking Business models
Digital customer journey, gamification and loyalty in Retail Banking Business models Simon-Kucher Banking Strategy Forum London London, 19 th April 2018 Jens Baumgarten Senior Partner Frankfurt office
More informationZS Medical Affairs Outlook Report Analysis of Field Medical Growth and Industry Trends
ZS Medical Affairs Outlook Report 2017 Analysis of Field Medical Growth and Industry Trends ZS Medical Affairs Outlook Report 2017 Analysis of Field Medical Growth and Industry Trends Forward by Sarah
More informationSECURING VALUE FOR MONEY IN OUTSOURCED CONTRACTS How Local Authorities Can Deliver Their Cost Reduction Remit
SECURING VALUE FOR MONEY IN OUTSOURCED CONTRACTS How Local Authorities Can Deliver Their Cost Reduction Remit Roger Warner, ISG ISG WHITE PAPER 2014 Information Services Group, Inc. All Rights Reserved
More informationA Successful Model for Outsourcing Core Labeling Activities
A Successful Model for Outsourcing Core Labeling Activities Increasing efficiency, enhancing quality, and delivering compliance Life Science organizations are expanding into new geographical regions to
More informationcopyright Value Chain Group all rights reserved
About the VCG VCG Mission Statement Goal Value Proposition Member View Process Transformation Framework (VRM) Value Reference Model (XRM) X Reference Model (VLM) Value Lifecycle Model (SOA-IM) Service
More information